BridgeBio Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBIO and other ETFs, options, and stocks.About BBIO
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.
BBIO Key Statistics
Stock Snapshot
With a market cap of 14.47B, BridgeBio Pharma(BBIO) trades at $74.38. The stock has a price-to-earnings ratio of -24.44.
As of 2026-11-06, BridgeBio Pharma(BBIO) stock has fluctuated between $73.19 and $75.70. The current price stands at $74.38, placing the stock +1.6% above today's low and -1.7% off the high.
The BridgeBio Pharma(BBIO)'s current trading volume is 3.16M, compared to an average daily volume of 3.56M.
In the last year, BridgeBio Pharma(BBIO) shares hit a 52-week high of $93.42 and a 52-week low of $60.55.
In the last year, BridgeBio Pharma(BBIO) shares hit a 52-week high of $93.42 and a 52-week low of $60.55.
BBIO News
BridgeBio Pharma (BBIO) just posted third quarter 2026 results that showed revenue of US$353.17 million and a reduced net loss of US$56.71 million, a combinatio...
...
BridgeBio Pharma reported third quarter 2026 revenue of US$353.17 million and a net loss of US$56.71 million, with higher year to date revenue and a smaller nin...
Analyst ratings
87%
of 23 ratingsMore BBIO News
Bridgebio Pharma ((BBIO)) has held its Q3 earnings call. Read on for the main highlights of the call. BridgeBio Pharma’s latest earnings call struck an upbeat...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.